Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-01-05 Sale | 2021-01-06 7:15 pm | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 35,000 | $0.9 | $31,500 | 104,789 (Indirect Direct) | View |
| 2019-09-27 Purchase | 2019-09-30 4:16 pm | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 10,000 | $1.18 | $11,800 | 44,786 (Indirect Direct) | View |
| 2019-08-22 Purchase | 2019-08-26 4:18 pm | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 10,000 | $1.555 | $15,550 | 34,786 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-15 Option Award | 2023-10-17 4:09 pm | N/A 2033-10-15 | Envoy Medical Inc. | COCH | Wells David R. Chief Financial Officer | 293,250 | $0 | 293,250 (Direct) | View |
| 2023-03-20 Option Award | 2023-03-22 7:56 pm | N/A 2033-03-20 | Heart Test Laboratories Inc. | HSCS | Wells David R. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-04-05 Option Award | 2021-04-07 4:10 pm | N/A 2031-04-05 | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-06-23 Exercise | 2020-06-24 08:22 am | N/A N/A | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 5,000 | $0.87 | 144,840 (Direct) | View |
| 2020-06-23 Exercise | 2020-06-24 08:22 am | 2019-12-11 2024-12-11 | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 5,000 | $0 | 144,840 (Direct) | View |
| 2020-06-08 Conversion | 2020-06-10 07:38 am | N/A N/A | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 10,350 | $0.87 | 134,789 (Direct) | View |
| 2020-06-08 Conversion | 2020-06-10 07:38 am | 2019-12-11 N/A | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 9 | $1143.68 | 134,789 (Direct) | View |
| 2020-04-09 Option Award | 2020-04-13 4:39 pm | N/A N/A | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 79,653 | $0 | 124,439 (Direct) | View |
| 2020-01-25 Option Award | 2020-01-28 5:02 pm | N/A 2030-01-25 | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-12-11 Option Award | 2019-12-11 5:54 pm | 2019-12-11 N/A | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 9 | $1143.68 | 148,435 (Direct) | View |
| 2019-12-11 Option Award | 2019-12-11 5:54 pm | N/A 2029-12-11 | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 148,426 | $0 | 148,435 (Direct) | View |
| 2019-05-13 Option Award | 2019-05-15 5:00 pm | N/A 2029-05-13 | ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer | 56,000 | $0 | 56,000 (Direct) | View |